readthroughSign in
CompanyFATENasdaqSan Diego, CA

Fate Therapeutics

Fate Therapeutics develops off-the-shelf cell therapies using engineered human induced pluripotent stem cells (iPSCs).

8-KNov 16Latest SEC filing
Nov 12Latest story